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ABSTRACT
Background: Osteoclasts are bone-resorbing multinuclear polykaryons essential for bone remodeling,
formed through cell fusion of mononuclear macrophagemonocyte lineage precursor cells upon stimulation by
the RANKRANKL system. Recent studies have revealed that a family of tetraspanin proteins, such as CD9, is
critically involved in the cell fusionpolykaryon formation of these cell types. Until now, however, there is limited
knowledge about the types of tetraspanins expressed in osteoclasts and their precursors.
Methods: The expression of different tetraspanin proteins in a monocytemacrophage-lineage osteoclast pre-
cursor cell line, RAW264.7, was cyclopedically investigated using RT-PCR with specific primers and quantita-
tive real-time RT-PCR. The function of two kinds of tetraspanins, Tspan-5 and NET-6, whose expression pat-
tern was altered by RANKL stimulation, was examined by transfecting gene-specific short-interfering RNAs into
these cell types.
Results: Of the 17 tetraspanins in mammalian hematopoietic cells, RAW264.7 cells express mRNA for 12 dif-
ferent kinds of tetraspanins, namely, CD9, CD37, CD53, CD63, CD81, CD82, CD151, NAG-2, NET-6, SAS,
Tspan-3, and Tspan-5. Interestingly, during their maturation into osteoclasts upon RANKL stimulation, the tran-
script for Tspan-5 is up-regulated, whereas that for NET-6 is down-regulated. Targeted inhibition of Tspan-5 by
using gene-specific RNA interference suppressed RANKL-induced cell fusion during osteoclastogenesis,
whereas inhibition of NET-6 augmented the osteoclastogenesis itself. These results suggest that Tspan-5 and
NET-6 have a reciprocal function during osteoclastogenesis, i.e., positive and negative regulation by Tspan-5
and NET-6, respectively. RANKL regulates osteoclastogenesis by altering the balances of these tetraspanin
proteins.
Conclusions: These data indicate that a diversity of tetraspanins is expressed in osteoclast precursors, and
that cell fusion during osteoclastogenesis is regulated by cooperation of distinct tetraspanin family proteins
such as Tspan-5 and NET-6. This study indicates that functional alterations of tetraspanin family proteins may
have therapeutic potential in diseases where osteoclasts play a major role, such as rheumatoid arthritis and os-
teoporosis.
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INTRODUCTION
Osteoclasts are bone-resorbing multinuclear giant
cells which are differentiated from macrophage
monocyte lineage precursors.1-3 In patients with
bone-resorbing disorders, such as rheumatoid arthri-
tis and osteoporosis, increased numbers of activated
osteoclasts cause the bone destruction seen in such
diseases.4,5 It has been established that osteoclasto-
genesis is mainly regulated by the RANK (the recep-
tor activator of nuclear factor κB)RANKL (RANK
ligand) system. However, the mechanism whereby
osteoclast precursors fuse with each other to form a
polykaryon was until recently a mystery.6,7
The tetraspanins, also referred to as the
transmembrane-4 superfamily (TM4SF), are charac-
terized by their four transmembrane domains and
comprise at least 20 distinct members in mammalian
hematopoietic cells, including CD9, CD37, CD53,
CD63, CD81 and CD151.8-11 One of the tetraspanins,
CD9, is a membrane glycoprotein (about 25 kDa),
which is expressed in a variety of cell types, and has
been implicated in the regulation of cell fusion during
osteoclastogenesis.12,13 However, virtually nothing is
known about the expression of different types of tet-
raspanin proteins in osteoclasts, except for CD9. Be-
cause multinucleation (i.e., polykaryon formation) is
a characteristic of osteoclasts that distinguishes them
from all other somatic cells, the identification of the
molecules responsible for this event is expected to
lead to the development of novel therapeutic agents
for controlling bone-resorbing diseases. To see the
whole views of regulation of osteoclast formation with
tetraspanin family proteins, it is necessary to encom-
pass the cyclopedic lists of tetraspanin expressed in
osteoclasts.
In this study, using RT-PCR methods with
transcript-specific primers, we investigated the
mRNA expression of the tetraspanin family proteins
expressed in an osteoclast precursor cell line, RAW
264.7. Furthermore, in order to identify the functions
of two of the tetraspanin expressed proteins, we ex-
amined the effect of targeted inhibitions by using
short interfering RNAs.
METHODS
CELL CULTURE
RAW264.7, a murine macrophagemonocyte lineage
cell line, was obtained from ATCC (ATCC#: TIB-71),
and cultured with α-MEM (Invitrogen, Carlsbad, CA,
USA) supplemented with 10% heat-inactivated fetal
calf serum (FCS; HyClone, Logan, UT, USA) and
penicillinstreptomycin (Invitrogen).13 RAW264.7 can
fully differentiate into mature osteoclast-like cells by
stimulation with RANKL, and is therefore commonly
used for a model system of in vitro osteoclastogene-
sis.14 In order to differentiate the cells into multinu-
clear osteoclasts, 50 ngml RANKL (PeproTech,
Rocky Hill, NJ, USA) was added to the medium and
incubated for 3―5 days.
RT-PCR AMPLIFICATION
Total RNAs of RAW264.7 cells were extracted using
TRIzolTM reagent (Invitrogen) and cDNAs were syn-
thesized with SuperScript III reverse transcriptase
(Invitrogen), according to the manufacturers’ proto-
col. To eliminate genomic DNA contamination, we
treated the RNA samples with DNaseI (Takara,
Kyoto, Japan) before cDNA synthesis. Specific
primer pairs (listed in Table 1) were used to amplify
cDNA. PCR amplification was performed for 25 cy-
cles at 95℃ for 45 seconds, at 55℃ for 30 seconds,
and at 72℃ for 1 minute. The products were electro-
phoresed on 2% agarose gel. The amplified PCR prod-
ucts were confirmed by their nucleotide sequencing
using ABI Dye terminator cycle sequencing with the
ABI PRISM 310 Genetic Analyzer (Applied Biosys-
tems, Foster City, CA, USA).
QUANTITATIVE REAL-TIME PCR
Relative quantification with real-time RT-PCR was
performed using an ABI PRISM 7900 (Applied Bio-
systems) with an Assay-on-Demand TaqMan probe
and relevant primers (Tspan-5, Assay ID #Mm
00497960_m1; NET-6 (Tspan-12), Assay ID #Mm
00481226_m1; GAPDH, Assay ID #Mm99999915_g1),
according to the manufacturer’s instructions. Isola-
tion of total RNA from RAW264.7 cells and cDNA
synthesis were performed as described above. Each
sample was assayed in triplicate and the median
threshold cycle (Ct) value was used to calculate the
relative concentration of transcripts. Values were nor-
malized against the level of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
RNA INTERFERENCE
A small interfering RNA duplex (siRNA) targeting
Tspan-5 and NET-6, and the control RNA duplex were
synthesized by, and purchased from, B-Bridge Inter-
national Inc. (Sunnyvale, CA, USA): Tspan-5 siRNA,
5’-GGAUCAAAGACCAGCUGUATT-3’, and NET-6
siRNA, 5’-GCUAAUUGGGGAGCUGUAAAATT-3’.
The synthesized 21-mer sense and antisense RNA
strands were hybridized. The transfection of hybrid-
ized siRNAs into RAW264.7 cells was performed us-
ing LipofectAmine2000 (Invitrogen) according to the
manufacturer’s instructions. After transfection, the
cells were incubated for 3 days in α-MEM supple-
mented with 10% FCS and antibiotics. Then, the cells
were fixed in citrate acetone fixative, stained for
tartrate-resistant acid phosphatase (TRAP) with a
staining kit (Sigma-Aldrich, St. Louis, MO, USA), and
observed by an inverted differential interference mi-
croscope (IX-71, Olympus, Tokyo, Japan), equipped
with a 20X objective (UPLSAPO, Olympus; N.A.～0.75).
The picture image was acquired on-line through a
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Table 1 Primer pairs used for RT-PCR to detect mRNA for diferent types of tetraspanin superfamily proteins. The expected 
molecular weight in base pairs (b.p.) is indicated. As a control the presence of mRNA for GAPDH was detected.
b.p.Reverse (5’ -3’)Forward (5’ -3’)
405GTCCGAGATAAACTGCTCCACTTGCTATTGGACTATGGCTCD9
463GGGAGAAAAAGAGCTTATCATTTGTGGGTTTGTCCTTCGTCD37
476AGCACCTGTATCACACATACTATGGAGTACTCTTCCGTAACD53
415ATGTTGATGCAGCAAGAATCTTCAGGTTGTCTTGAAGCAGCD63
503GCTACCACAATGGCTGCAATTACCTGGAACTGGGAAACAACD81
436TCTTCACAATGAGCTGGTTGTACAAACCTCATCCAGCTCGCD82
463TAGTCTTACAGCAGCTGTCAAGTGACTACATTAGTCTGCTCD151
449ACTGATTGGCAGTGATGAACTGTTCCTGGCTGAGCTTGTTCD231
564TTTACCACCTGGCAGTACATATCATCCTCATTTCCATCCTNAG-2
654AGTAATGGTGAGAATCATGGATCAGTGTCTTGGCAGTTTCNET-2
344GCACGTGCTTGTTGTCATCATTGATCATCCTGCTGGCAGANET-5
397CAAACCTCAAAACCTCTCCATTTGGGCTGATCTCCAGTCTNET-6
393GTCTGAATGTTTAAGGAACCGTGGTGTCTAGCATTCACATSAS
427GGTTTCAATTTTGTCGATGCGGAGGTACCATGAAGGATTTTspan-2
523TTCACAACAAGAGCCTCACACTATGTCTTCATCACCTATGTspan-3
676TGTCCTGTAGCCACTTCTCAAAGGGTCCTGAAGTCAGTTGTspan-5
556GAAGCAATACTGTAGTGTGTTACTGATCACCAACTTCCTATssc6
cooled CCD (ORCA 3CCD; Hamamatsu Photonics,
Hamamatsu, Japan) and processed with data acquisi-
tion software (Aquacosmos; Hamamatsu Photonics).
For the evaluation of osteoclastogenesis, nuclei of
multinucleated (more than four nuclei) TRAP-positive
cells were counted using light microscopy. More
than 1000 nuclei in ten visual fields from three inde-
pendent experiments were counted. The reduction of
the amount of mRNAs in the targeted cells by these
siRNAs was assessed by conventional RT-PCR using
their specific primers, as described above. The ex-
pression of NFATc1 was also assessed by conven-
tional RT-PCR as previously described.15
STATISTICS
All results are expressed as the mean ± standard er-
ror (s.e.m.) obtained from n experiments. Statistical
differences were evaluated by unpaired Student’s t-
tests. Statistical probability values of p < 0.05 were
considered to indicate significant differences.
RESULTS
EXPRESSION PROFILE OF TETRASPANIN SU-
PERFAMILY PROTEINS IN AN OSTEOCLAST
PRECURSOR CELL LINE
In the RT-PCR analysis of total RNA extracted from
RAW264.7 cell lines cultured in the absence or pres-
ence of RANKL-stimulation, oligonucleotide primers
for 12 kinds of tetraspanin superfamily proteins
showed an amplification of products of expected sizes
(Fig. 1A): CD9, CD37, CD53, CD63, CD81, CD82,
CD151, NAG-2, NET-6, SAS, Tspan-3, and Tspan-5.
These amplified products were confirmed by their
nucleotide sequencing. As a control, the presence of
mRNA for GAPDH was examined, and it was found to
be present at the expected molecular sizes (Fig. 1A).
Upon RANKL stimulation, mRNA for Tspan-5 was
shown to be up-regulated, whereas that for NET-6, on
the other hand, was down-regulated (Fig. 1A). On the
other hand, the expression of other tetraspanins, i.e.,
CD9, CD37, CD53, CD63, CD81, CD82, CD151, NAG-
2, SAS, and Tspan-3 were not significantly altered at
least in mRNA levels.
Expression of Tspan-5 and NET-6 was also exam-
ined quantitatively by real-time RT-PCR using a
TaqMan probe and relevant primers (Fig. 1B). Upon
stimulation of osteoclastogenic RANKL signaling,
Tspan-5 mRNA was promptly increased to 2.5-folds in
1 day after, and the up-regulation was sustained for
up to 4 days (Fig. 1B, upper panel). On the other
hand, the transcription of NET-6 was down-regulated
to about 15 one day after RANKL stimulation but its
level was gradually recovered (Fig. 1B, lower panel).
This result may suggest that the suppression of NET-
6 expression is important in the earlier phase of os-
teoclastogenic cell fusion.
TARGETED INHIBITION OF TWO TETRASPANIN
PROTEINS, TSPAN-5 AND NET-6
Of the 12 tetraspanin proteins expressed in RAW
264.7 cells, we took special notice of Tspan-5 and
NET-6, because their expressions are changed in re-
sponse to RANKL stimulation, suggesting their sig-
nificant roles in osteoclastogenesis. To investigate
the role of these tetraspanin proteins on osteoclasto-
genesis, we examined the effect of inhibiting their
functions with short interfering RNAs (siRNAs) tar-
geting mouse Tspan-5 and NET-6 (Fig. 2). The siR-
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Fig. 1 (A) RT-PCR analysis of mRNA encoding 17 diferent kinds of mammalian 
tetraspanin superfamily proteins expressed in an osteoclast precursor cel line, 
RAW264.7, cultured in the absence (RANKL (－) or presence (RANKL (＋) of 
RANKL. As a control, mRNA for GAPDH was detected. RT (＋), PCR with synthe-
sized cDNA; RT (－), negative controls without reverse transcriptase. The numbers 
on the left side indicate the positions of molecular weight markers in base pairs 
(b.p.) (B) Time-courses of expression of Tspan-5 (a) and NET-6 (b), examined us-
ing quantitative real-time RT-PCR analysis. RAW264.7 cels were cultured in the 
presence (filed circle) or absence (open circle) of RANKL for up to 4 days.
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NAs and its control RNA duplex were generated and
transfected into RAW264.7 cells. According to the ba-
sic experiments for expressing green fluorescent pro-
tein, the transfection efficiency in these cell types was
estimated to be approximately 40―60% (data not
shown).13 The reduction of the amount of Tspan-5
and NET-6 mRNAs in the targeted cells by these siR-
NAs was assessed by RT-PCR using gene specific
primers (Fig. 2A). These siRNA potently inhibited
the mRNA expression to about 50% in Tspan-5 (Fig. 2
Aa) or to about 60% in NET-6 (Fig. 2Ab) at the tran-
script levels. On the other hand, the transcription of
NFATc1, a transcription factor crucial for osteoclasto-
genesis16 (Fig. 2A, lower panels), as well as those of
other osteoclast markers, such as c-fos, RANK and αv
integrin (data not shown), were not significantly al-
tered, suggesting that neither Tspan-5 nor NET-6 are
involved in general osteoclastogenic signaling cas-
cades.
Next, the transfection cells were cultured for 3
days in the presence of RANKL to induce differentia-
tion. The results showed that the formation of
osteoclast-like polykaryons was reduced by the inhi-
bition of Tspan-5 expression (Fig. 2Bb). Interestingly,
Tetraspanin Proteins in Osteoclast Cell Fusion
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Fig. 2. Targeted inhibition of Tspan-5 and NET-6 using gene-specific short-interfering 
RNA (siRNA). (A) Reduction of mRNAs of Tspan-5 (a) and NET-6 (b) assessed by RT-
PCR analysis. Expression of NFATc1, one of the transcriptional factors crucial for osteo-
clast maturation, was not significantly altered at the transcriptional level by the siRNA 
treatment. (B) Representative images of RANKL-treated RAW264.7 cels (a) in control 
conditions, and (b) transfected with Tspan-5 siRNA and (c) with NET-6 siRNA. Compared 
with the control conditions (a), the decrease of Tspan-5 transcript by siRNA inhibits osteo-
clastogenesis (b), whereas that of NET-6 prominently enhances osteoclastogenesis and 
the formation of giant polykaryons (c). Scale bars represent 50 μm. (d) Number of nuclei 
within TRAP (＋)-multinucleated cels (cels with more than 4 nuclei) per visual field. Eror 
bars represent ± s. e. m. ＊represents p＜0.05. n.s., not significantly diferent. More than 
1000 nuclei in ten visual fields were counted, and the results were essentialy consistent in 
three independent experiments.
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on the other hand, upon the decrease in NET-6 ex-
pression, the cells were found to differentiate into
TRAP-positive osteoclasts to form giant polykaryons
more efficiently than the cells in control conditions
(Fig. 2Bc). These results clearly demonstrated the re-
ciprocal function of the two tetraspanin proteins,
Tspan-5 and NET-6, in osteoclastogenesis; i.e., posi-
tive regulation by Tspan-5 and negative regulation by
NET-6. It is suggested that RANKL stimulation facili-
tates osteoclastogenesis by enhancing the expression
of the positive regulator, Tspan-5, and by inhibiting
expression of the negative regulator, NET-6.
DISCUSSION
One of the major characteristics of bone-resorptive
osteoclasts is cell fusion and multinucleation during
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their maturation into giant polykaryons. Tetraspanins
are well known to be critically involved in the process
of cell fusion, which includes osteoclastogene-
sis.12,13,16-20 Nevertheless, the tetraspanin superfamily
consists of at least 20 subtypes, and it is still unsolved
which subtypes are specifically responsible for osteo-
clastogenesis. In the current study, we revealed the
redundant expression of mRNAs for 12 members
among 17 mammalian hematopoietic tetraspanins,
such as CD9, CD37, CD53, CD63, CD81, CD82,
CD151, NAG-2, NET-6, SAS, Tspan-3, and Tspan-5.
We found that two of the tetraspanin proteins, Tspan-
5 and NET-6, are dynamically regulated by osteoclas-
togenic RANKL signaling at the transcriptional level.
This case shows a marked contrast to that of CD9,
whose membrane localization (especially to a specific
membrane microdomain called “lipid raft”) is regu-
lated by RANKL stimulation.13
Regarding the role of tetraspanins in osteoclasto-
genesis, there is some controversy. Although most
previous reports have indicated that tetraspanins are
crucial for the formation of polykaryons including os-
teoclasts,13,17-21 one report has shown that tetras-
panins such as CD9 and CD81 do not promote but
rather inhibit multinucleated osteoclast formation, by
using CD9- and CD81-global knockout mice.12 Given
the severe redundancy and crucial role of tetras-
panins in osteoclasts, we can reasonably speculate
that some other tetraspanins, i.e., CD37, CD53,
CD63, CD82, CD151, NAG-2, NET-6, SAS, Tspan-3,
and Tspan-5, are up-regulated and possibly compen-
sate the losses-of-function of CD9 and CD81.
Of the 12 expressed tetraspanins, two molecules,
Tspan-5 and NET-6, are worthy of note, because their
mRNA expressions are altered upon stimulation by
RANKRANKL signaling, and they have reciprocal
roles in osteoclastogenesis. This case shows a
marked contrast to that of CD9, whose membrane lo-
calization (especially to a specific membrane micro-
domain called “lipid raft”) is regulated by RANKL
stimulation.13 Tspan-5, whose expression in osteo-
clast precursors was up-regulated by RANKL and
thus has a positive regulator of osteoclast maturation,
has previously been shown to be abundantly ex-
pressed in the brain and to be involved in the devel-
opment of the central nervous system.22-24 It has also
been reported that Tspan-5 is expressed in unique
natural killer (NK) cell subsets detected in the uter-
ine decidua in early pregnancy.25 NET-6, also re-
ferred as Tspan-13, a negative regulator of osteoclas-
togenesis, is known as a kind of aberrantly expressed
cell marker in breast cancers, and is thought to play a
role in mammary neoplasia.26 Despite the studies re-
vealing the expression profiles, the specific function
of these tetraspanins, Tspan-5 and NET-6, remained
unsolved.
It is an intriguing, but still unanswered, question
how these different tetraspanin proteins exhibit con-
tradictory functions in cell fusion. In general, tetras-
panin proteins are known to function as organizers of
multimolecular membrane complexes (“tetraspanin
web”), by composing a certain lipid microdomain,
designated as a “tetraspanin-enriched microdomain
(TEM)”.10,11 Then it can be suggested that Tspan-5
and NET-6 form their webs cooperatively or respec-
tively on the cell membrane and recruit unknown cis-
interacting partners important for osteoclast cell fu-
sion. Otherwise, they may behave competitively to
unknown ligands for stimulating cell fusion. Further
studies are needed to clarify the molecular functions
of tetraspanin proteins in this scheme.
In conclusion, we revealed the redundant expres-
sion of the tetraspanin superfamily proteins in osteo-
clast precursor cell lines CD9, CD37, CD53, CD63,
CD81, CD82, CD151, NAG-2, NET-6, SAS, Tspan-3,
and Tspan-5, and specific reciprocal functions of
Tspan-5 and NET-6. This finding may contribute to an
overall understanding of tetraspanin-regulated cell fu-
sion during osteoclastogenesis, which has recently
emerged as a novel therapeutic target for bone-
resorbing disorders.
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